Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altimmune, Inc. (ALT) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Altimmune, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1326190.
Total stock buying since 2007: $41,478,215.
Total stock sales since 2007: $9,994,318.
Total stock option exercises since 2007: $4,213,050.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 10,000 | $52,000 | 0 | $0 | 194,552 | $0 |
| 2024 | 0 | $0 | 16,011 | $110,555 | 169,102 | $106,462 |
| 2023 | 29,300 | $124,631 | 0 | $0 | 75,878 | $0 |
| 2022 | 2,200 | $13,400 | 165,302 | $1,959,180 | 204,919 | $341,787 |
| 2021 | 0 | $0 | 6,000 | $96,479 | 209 | $501 |
| 2020 | 2,805,636 | $22,558,135 | 236,669 | $1,347,439 | 109,585 | $144 |
| 2019 | 20,000 | $42,000 | 0 | $0 | 0 | $0 |
| 2018 | 3,300 | $9,840 | 0 | $0 | 238,467 | $19,076 |
| 2017 | 501,624 | $981,870 | 0 | $0 | 273,377 | $300,780 |
| 2016 | 0 | $0 | 1,695,753 | $5,162,159 | 1,999,204 | $3,379,804 |
| 2015 | 25,000 | $41,225 | 29,600 | $62,160 | 29,600 | $33,448 |
| 2014 | 15,000 | $23,175 | 0 | $0 | 0 | $0 |
| 2011 | 125,552 | $176,689 | 339,855 | $1,256,346 | 11,651 | $31,048 |
| 2010 | 2,790,000 | $9,344,082 | 0 | $0 | 0 | $0 |
| 2009 | 175,000 | $207,849 | 461,098 | $0 | 0 | $0 |
| 2008 | 138,000 | $152,319 | 0 | $0 | 0 | $0 |
| 2007 | 1,015,000 | $7,751,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 10,000 | $52,000 | 0 | $0 | 0 | $0 |
| 2025-02 | 0 | $0 | 0 | $0 | 63,377 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 131,175 | $0 |
| 2024-08 | 0 | $0 | 16,011 | $110,555 | 41,750 | $106,462 |
| 2024-02 | 0 | $0 | 0 | $0 | 63,377 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 63,975 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2023-08 | 300 | $862 | 0 | $0 | 0 | $0 |
| 2023-03 | 29,000 | $123,769 | 0 | $0 | 0 | $0 |
| 2023-02 | 0 | $0 | 0 | $0 | 63,378 | $0 |
| 2022-12 | 0 | $0 | 20,000 | $300,260 | 57,500 | $52,000 |
| 2022-08 | 0 | $0 | 17,714 | $266,595 | 0 | $0 |
| 2022-07 | 0 | $0 | 37,164 | $445,968 | 27,769 | $77,196 |
| 2022-06 | 1,000 | $8,000 | 60,424 | $720,757 | 60,703 | $154,793 |
| 2022-05 | 1,200 | $5,400 | 0 | $0 | 0 | $0 |
| 2022-02 | 0 | $0 | 30,000 | $225,600 | 58,877 | $57,630 |
| 2022-01 | 0 | $0 | 0 | $0 | 70 | $168 |
| 2021-12 | 0 | $0 | 0 | $0 | 139 | $333 |
| 2021-11 | 0 | $0 | 0 | $0 | 70 | $168 |
| 2021-03 | 0 | $0 | 6,000 | $96,479 | 0 | $0 |
| 2020-12 | 2,000 | $23,980 | 1,227 | $16,613 | 0 | $0 |
| 2020-11 | 0 | $0 | 35,442 | $373,726 | 60 | $144 |
| 2020-09 | 0 | $0 | 0 | $0 | 109,525 | $0 |
| 2020-06 | 1,500,000 | $11,310,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-13 | Weaver Gregory L (Chief Financial Officer) | Buy | 10,000 | 5.20 | 52,000 |
| 2025-02-02 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 7,775 | .00 | 0 |
| 2025-02-02 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 7,775 | .00 | 0 |
| 2025-02-02 | Garg Vipin K (President and CEO) | Option Ex | 18,950 | .00 | 0 |
| 2025-02-01 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 6,166 | .00 | 0 |
| 2025-02-01 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 6,166 | .00 | 0 |
| 2025-02-01 | Garg Vipin K (President and CEO) | Option Ex | 16,545 | .00 | 0 |
| 2025-01-30 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 9,275 | .00 | 0 |
| 2025-01-30 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 9,275 | .00 | 0 |
| 2025-01-30 | Garg Vipin K (President and CEO) | Option Ex | 26,775 | .00 | 0 |
| 2025-01-25 | Jordt Raymond M (Chief Business Officer) | Option Ex | 14,600 | .00 | 0 |
| 2025-01-25 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 14,600 | .00 | 0 |
| 2025-01-25 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 14,600 | .00 | 0 |
| 2025-01-25 | Garg Vipin K (President and CEO) | Option Ex | 42,050 | .00 | 0 |
| 2024-08-19 | Drutz David | Sale | 16,011 | 6.91 | 110,555 |
| 2024-08-19 | Drutz David | Option Ex | 41,750 | 2.55 | 106,462 |
| 2024-02-02 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 7,775 | .00 | 0 |
| 2024-02-02 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 7,775 | .00 | 0 |
| 2024-02-02 | Garg Vipin K (President and CEO) | Option Ex | 18,950 | .00 | 0 |
| 2024-02-01 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 6,166 | .00 | 0 |
| 2024-02-01 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 6,166 | .00 | 0 |
| 2024-02-01 | Garg Vipin K (President and CEO) | Option Ex | 16,545 | .00 | 0 |
| 2024-01-30 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 9,275 | .00 | 0 |
| 2024-01-30 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 9,275 | .00 | 0 |
| 2024-01-30 | Garg Vipin K (President and CEO) | Option Ex | 26,775 | .00 | 0 |
| 2024-01-30 | Eisenstadt Richard I (Chief Financial Officer) | Option Ex | 9,275 | .00 | 0 |
| 2024-01-01 | Jordt Raymond M (Chief Business Officer) | Option Ex | 9,375 | .00 | 0 |
| 2023-12-29 | Eisenstadt Richard I (Chief Financial Officer) | Option Ex | 12,500 | .00 | 0 |
| 2023-08-15 | Drutz David | Buy | 300 | 2.88 | 862 |
| 2023-03-24 | Eisenstadt Richard I (Chief Financial Officer) | Buy | 10,000 | 4.31 | 43,140 |
| 2023-03-23 | Harris Matthew Scott (Chief Medical Officer) | Buy | 10,000 | 4.22 | 42,200 |
| 2023-03-23 | Drutz David | Buy | 9,000 | 4.27 | 38,429 |
| 2023-02-02 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 7,775 | .00 | 0 |
| 2023-02-02 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 7,775 | .00 | 0 |
| 2023-02-02 | Garg Vipin K (President and CEO) | Option Ex | 18,950 | .00 | 0 |
| 2023-02-01 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 6,166 | .00 | 0 |
| 2023-02-01 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 6,166 | .00 | 0 |
| 2023-02-01 | Garg Vipin K (President and CEO) | Option Ex | 16,546 | .00 | 0 |
| 2022-12-31 | Eisenstadt Richard I (Chief Financial Officer) | Option Ex | 25,000 | .00 | 0 |
| 2022-12-22 | Pisano Wayne | Sale | 20,000 | 15.01 | 300,260 |
| 2022-12-22 | Pisano Wayne | Option Ex | 20,000 | 2.60 | 52,000 |
| 2022-08-12 | Garg Vipin K (President and CEO) | Sale | 15,000 | 15.06 | 225,885 |
| 2022-08-12 | Gill John | Sale | 2,714 | 15.00 | 40,710 |
| 2022-07-05 | Roberts M Scot (Chief Scientific Officer) | Sale | 10,182 | 12.00 | 122,184 |
| 2022-07-05 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 787 | 2.95 | 2,321 |
| 2022-07-01 | Roberts M Scot (Chief Scientific Officer) | Sale | 26,982 | 12.00 | 323,784 |
| 2022-07-01 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 26,982 | 2.77 | 74,875 |
| 2022-06-29 | Roberts M Scot (Chief Scientific Officer) | Sale | 5,462 | 12.00 | 65,544 |
| 2022-06-29 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 5,462 | 2.60 | 14,201 |
| 2022-06-27 | Roberts M Scot (Chief Scientific Officer) | Sale | 37,352 | 12.00 | 448,261 |
| 2022-06-27 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 37,352 | 2.26 | 84,452 |
| 2022-06-27 | Jorkasky Diane | Sale | 17,610 | 11.75 | 206,952 |
| 2022-06-27 | Jorkasky Diane | Option Ex | 17,610 | 3.15 | 55,471 |
| 2022-06-20 | Schafer Klaus | Option Ex | 279 | 2.40 | 669 |
| 2022-06-15 | Drutz David | Buy | 1,000 | 8.00 | 8,000 |
| 2022-05-24 | Drutz David | Buy | 1,200 | 4.50 | 5,400 |
| 2022-02-28 | Harris Matthew Scott (Chief Medical Officer) | Sale | 30,000 | 7.52 | 225,600 |
| 2022-02-28 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 30,000 | 1.92 | 57,630 |
| 2022-02-01 | Harris Matthew Scott (Chief Medical Officer) | Option Ex | 6,166 | .00 | 0 |
| 2022-02-01 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 6,166 | .00 | 0 |
| 2022-02-01 | Garg Vipin K (President and CEO) | Option Ex | 16,545 | .00 | 0 |
| 2022-01-25 | Drutz David | Option Ex | 70 | 2.40 | 168 |
| 2021-12-14 | Drutz David | Option Ex | 139 | 2.40 | 333 |
| 2021-11-19 | Drutz David | Option Ex | 70 | 2.40 | 168 |
| 2021-03-01 | Hodges Philip (Director) | Sale | 6,000 | 16.08 | 96,479 |
| 2020-12-10 | Schafer Klaus (Director) | Buy | 2,000 | 11.99 | 23,980 |
| 2020-12-01 | Hodges Philip (Director) | Sale | 1,227 | 13.54 | 16,613 |
| 2020-11-30 | Hodges Philip (Director) | Sale | 2,500 | 12.00 | 30,000 |
| 2020-11-30 | Gill John (Director) | Sale | 8,425 | 11.92 | 100,426 |
| 2020-11-13 | Drutz David (Director) | Option Ex | 60 | 2.40 | 144 |
| 2020-11-12 | Harris Matthew Scott (Director) | Sale | 4,015 | 10.02 | 40,230 |
| 2020-11-12 | Pisano Wayne (Director) | Sale | 10,352 | 9.90 | 102,484 |
| 2020-11-12 | Schafer Klaus (Director) | Sale | 10,150 | 9.91 | 100,586 |
| 2020-09-24 | Pisano Wayne (Director) | Option Ex | 16,850 | .00 | 0 |
| 2020-09-24 | Schafer Klaus (Director) | Option Ex | 16,850 | .00 | 0 |
| 2020-09-24 | Hodges Philip (Director) | Option Ex | 16,850 | .00 | 0 |
| 2020-09-24 | Drutz David (Director) | Option Ex | 16,850 | .00 | 0 |
| 2020-09-24 | Gill John (Director) | Option Ex | 16,850 | .00 | 0 |
| 2020-09-24 | Sayare Mitchel (Director) | Option Ex | 25,275 | .00 | 0 |
| 2020-06-15 | Shah Nimish P (10% Owner) | Buy | 1,500,000 | 7.54 | 11,310,000 |
| 2020-05-28 | Shah Nimish P (10% Owner) | Buy | 201,474 | 8.33 | 1,678,278 |
| 2020-05-27 | Shah Nimish P (10% Owner) | Buy | 402,162 | 7.58 | 3,046,377 |
| 2020-05-26 | Shah Nimish P (10% Owner) | Buy | 700,000 | 9.29 | 6,499,500 |
| 2020-05-15 | Velocity Pharmaceutical Holdings Llc (10% Owner) | Sale | 30,622 | 4.65 | 142,392 |
| 2020-05-14 | Velocity Pharmaceutical Holdings Llc (10% Owner) | Sale | 169,378 | 4.81 | 814,708 |
| 2019-09-05 | Garg Vipin K (President and CEO) | Buy | 20,000 | 2.10 | 42,000 |
| 2018-10-09 | Pisano Wayne (Director) | Buy | 2,000 | 4.59 | 9,180 |
| 2018-05-25 | Enright William (President and CEO) | Buy | 1,300 | .51 | 660 |
| 2018-05-21 | Roberts M Scot (Chief Scientific Officer) | Option Ex | 55,120 | .08 | 4,409 |
| 2018-01-02 | Enright William (President and CEO) | Option Ex | 183,347 | .08 | 14,667 |
| 2017-12-29 | Sayare Mitchel (Director) | Buy | 5,100 | 1.95 | 9,965 |
| 2017-12-29 | Schaffer Derace L (Director) | Buy | 38,699 | 1.93 | 74,766 |
| 2017-12-28 | Schaffer Derace L (Director) | Buy | 58,711 | 1.92 | 112,666 |
| 2017-12-27 | Schaffer Derace L (Director) | Buy | 77,706 | 1.77 | 137,306 |
| 2017-12-26 | Schaffer Derace L (Director) | Buy | 51,442 | 1.81 | 93,264 |
| 2017-12-22 | Schaffer Derace L (Director) | Buy | 17,982 | 1.61 | 28,879 |
| 2017-12-07 | Schaffer Derace L (Director) | Buy | 7,639 | 1.74 | 13,307 |
| 2017-12-06 | Schaffer Derace L (Director) | Buy | 16,106 | 1.80 | 28,990 |
| 2017-12-05 | Schaffer Derace L (Director) | Buy | 13,495 | 1.78 | 23,994 |
| 2017-12-04 | Schaffer Derace L (Director) | Buy | 7,300 | 1.81 | 13,198 |
| 2017-12-01 | Schaffer Derace L (Director) | Buy | 5,215 | 1.80 | 9,402 |
| 2017-11-30 | Schaffer Derace L (Director) | Buy | 12,978 | 1.83 | 23,814 |
| 2017-11-29 | Schaffer Derace L (Director) | Buy | 7,942 | 1.94 | 15,375 |
| 2017-11-28 | Schaffer Derace L (Director) | Buy | 12,395 | 1.97 | 24,442 |
| 2017-11-27 | Schaffer Derace L (Director) | Buy | 10,042 | 2.00 | 20,063 |
| 2017-11-24 | Schaffer Derace L (Director) | Buy | 6,505 | 2.02 | 13,159 |
| 2017-11-22 | Schaffer Derace L (Director) | Buy | 5,261 | 2.10 | 11,058 |
| 2017-11-21 | Schaffer Derace L (Director) | Buy | 7,236 | 2.06 | 14,906 |
| 2017-11-20 | Schaffer Derace L (Director) | Buy | 4,800 | 2.08 | 9,960 |
| 2017-11-17 | Schaffer Derace L (Director) | Buy | 6,295 | 2.12 | 13,351 |
| 2017-08-25 | Schaffer Derace L (Director) | Buy | 50,000 | 2.25 | 112,400 |
| 2017-08-24 | Schaffer Derace L (Director) | Buy | 17,326 | 2.25 | 38,896 |
| 2017-08-23 | Drutz David (Director) | Buy | 5,000 | 2.27 | 11,339 |
| 2017-08-23 | Schaffer Derace L (Director) | Buy | 43,352 | 2.22 | 96,371 |
| 2017-08-22 | Drutz David (Director) | Buy | 5,000 | 2.15 | 10,760 |
| 2017-08-22 | Schaffer Derace L (Director) | Buy | 5,958 | 2.10 | 12,517 |
| 2017-08-21 | Schaffer Derace L (Director) | Buy | 690 | 2.02 | 1,394 |
| 2017-08-16 | Enright William (President and CEO) | Option Ex | 163,377 | .08 | 13,070 |
| 2017-06-06 | Roberts M Scot (Chief Scientific Officer) | Buy | 449 | 4.42 | 1,984 |
| 2017-06-02 | Gill John (Director) | Buy | 1,000 | 4.34 | 4,344 |
| 2017-01-20 | Runge Jeffrey W. | Option Ex | 20,000 | 3.11 | 62,200 |
| 2017-01-13 | Schaffer Derace L | Option Ex | 20,000 | 2.20 | 44,000 |
| 2017-01-04 | St Peter Steven | Option Ex | 70,000 | 2.59 | 181,510 |
| 2016-12-21 | Macneill Philip (VP, CFO, Treasurer, Secretary) | Option Ex | 22,657 | 1.69 | 38,177 |
| 2016-12-09 | Frohlich Phil (10% Owner) | Sale | 436,324 | 3.26 | 1,422,416 |
| 2016-12-08 | Frohlich Phil (10% Owner) | Sale | 440,479 | 3.25 | 1,431,556 |
| 2016-12-07 | Frohlich Phil (10% Owner) | Sale | 477,829 | 3.26 | 1,557,722 |
| 2016-11-28 | Runge Jeffrey W. | Option Ex | 20,000 | 2.20 | 44,000 |
| 2016-11-22 | Gill John (President and CEO) | Option Ex | 100,000 | 2.20 | 220,000 |
| 2016-11-22 | Richman Eric I | Option Ex | 483,733 | 1.86 | 902,162 |
| 2016-11-22 | Sayare Mitchel | Option Ex | 270,500 | 1.88 | 507,457 |
| 2016-09-30 | Schaffer Derace L | Option Ex | 130,000 | 1.85 | 240,500 |
| 2016-09-28 | Richman Eric I | Option Ex | 237,500 | 1.39 | 330,837 |
| 2016-09-20 | Macneill Philip (VP, CFO, Treasurer, Secretary) | Option Ex | 53,689 | 1.48 | 79,298 |
| 2016-09-16 | Gill John (President and CEO) | Option Ex | 30,000 | 2.53 | 75,900 |
| 2016-09-16 | St Peter Steven | Option Ex | 110,004 | 1.62 | 177,876 |
| 2016-09-15 | Runge Jeffrey W. | Option Ex | 120,000 | 1.54 | 184,800 |
| 2016-09-15 | Gill John (President and CEO) | Option Ex | 80,000 | 1.55 | 124,000 |
| 2016-04-13 | Richman Eric I | Sale | 329,354 | 2.20 | 724,578 |
| 2016-04-13 | Richman Eric I | Option Ex | 329,354 | 1.32 | 434,088 |
| 2016-04-08 | Richman Eric I | Sale | 6,400 | 2.20 | 14,080 |
| 2016-04-08 | Richman Eric I | Option Ex | 6,400 | 1.76 | 11,264 |
| 2016-04-07 | Richman Eric I | Sale | 5,367 | 2.20 | 11,807 |
| 2016-04-07 | Richman Eric I | Option Ex | 5,367 | 1.76 | 9,445 |
| 2015-03-19 | St Peter Steven | Buy | 25,000 | 1.65 | 41,225 |
| 2015-01-07 | Chang Linda L (SVP, CFO & Secretary) | Sale | 29,600 | 2.10 | 62,160 |
| 2015-01-07 | Chang Linda L (SVP, CFO & Secretary) | Option Ex | 29,600 | 1.13 | 33,448 |
| 2014-09-22 | Frohlich Phil (10% Owner) | Buy | 15,000 | 1.54 | 23,175 |
| 2011-12-12 | Runge Jeffrey W. | Buy | 20,000 | 1.30 | 26,000 |
| 2011-11-22 | Fuerst Thomas Richard (SVP, Chief Scientific Officer) | Buy | 5,000 | 1.27 | 6,350 |
| 2011-11-16 | Chang Linda L (SVP & CFO) | Buy | 10,000 | 1.38 | 13,839 |
| 2011-11-10 | Fuerst Thomas Richard (EVP, Chief Scientific Officer) | Buy | 10,000 | 1.51 | 15,100 |
| 2011-11-10 | Karp Jordan P (SVP, General Counsel) | Buy | 10,000 | 1.51 | 15,060 |
| 2011-11-10 | Richman Eric I (President and CEO) | Buy | 10,000 | 1.50 | 15,029 |
| 2011-08-25 | Schaffer Derace L | Buy | 16,800 | .70 | 11,760 |
| 2011-08-24 | Schaffer Derace L | Buy | 20,902 | .70 | 14,631 |
| 2011-08-18 | Sayare Mitchel | Buy | 5,000 | 2.17 | 10,850 |
| 2011-06-17 | Runge Jeffrey W. (Director) | Buy | 17,850 | 2.69 | 48,070 |
| 2011-05-31 | Riddle Valerie D (SVP, Medical Director) | Sale | 8,792 | 4.00 | 35,211 |
| 2011-05-31 | Riddle Valerie D (SVP, Medical Director) | Option Ex | 3,438 | 2.46 | 8,457 |
| 2011-05-25 | Riddle Valerie D (SVP, Medical Director) | Sale | 4,775 | 3.75 | 17,906 |
| 2011-05-25 | Riddle Valerie D (SVP, Medical Director) | Option Ex | 4,775 | 2.96 | 14,134 |
| 2011-05-25 | Pappajohn John (Director) | Sale | 50,000 | 3.68 | 184,150 |
| 2011-05-23 | Riddle Valerie D (SVP, Medical Director) | Sale | 8,791 | 3.65 | 32,131 |
| 2011-05-23 | Riddle Valerie D (SVP, Medical Director) | Option Ex | 3,438 | 2.46 | 8,457 |
| 2011-05-19 | Schaffer Derace L (Director) | Sale | 142,497 | 3.68 | 524,673 |
| 2011-05-18 | Schaffer Derace L (Director) | Sale | 50,000 | 3.68 | 183,950 |
| 2011-05-17 | Schaffer Derace L (Director) | Sale | 75,000 | 3.71 | 278,325 |
| 2010-11-03 | Mpm Asset Management Investors 2004 Bviii Llc (10% Owner) | Buy | 1,290,000 | 3.50 | 4,515,000 |
| 2010-11-03 | Simon Nicholas J Iii (10% Owner) | Buy | 430,000 | 3.50 | 1,505,000 |
| 2010-06-17 | Richman Eric I (President and Interim CEO) | Buy | 10,000 | 1.58 | 15,770 |
| 2010-05-27 | Pappajohn John (Director) | Buy | 45,656 | 1.51 | 68,940 |
| 2010-05-26 | Pappajohn John (Director) | Buy | 54,344 | 1.49 | 80,863 |
| 2010-05-18 | Schaffer Derace L (Director) | Buy | 83,253 | 1.50 | 124,712 |
| 2010-05-17 | Schaffer Derace L (Director) | Buy | 16,747 | 1.42 | 23,797 |
| 2009-12-11 | Wright David P (President and CEO) | Buy | 25,000 | 1.16 | 28,949 |
| 2009-12-11 | Schaffer Derace L (Director) | Buy | 50,000 | 1.20 | 60,000 |
| 2009-12-11 | Pappajohn John (Director) | Buy | 100,000 | 1.19 | 118,900 |
| 2009-03-26 | Schaffer Derace L (Director) | Sale | 17,735 | .00 | 0 |
| 2009-03-26 | Pappajohn John (Director) | Sale | 17,735 | .00 | 0 |
| 2009-03-12 | Schaffer Derace L (Director) | Sale | 212,814 | .00 | 0 |
| 2009-03-12 | Pappajohn John (Director) | Sale | 212,814 | .00 | 0 |
| 2008-12-01 | Wright David P (President and CEO) | Buy | 13,000 | .95 | 12,350 |
| 2008-11-25 | Wright David P (President and CEO) | Buy | 700 | .98 | 686 |
| 2008-11-21 | Wright David P (President and CEO) | Buy | 16,500 | .93 | 15,345 |
| 2008-11-20 | Wright David P (President and CEO) | Buy | 50,000 | .98 | 49,000 |
| 2008-11-19 | Price Kevin (President-Pharmathene UK, Ltd.) | Buy | 2,500 | .95 | 2,375 |
| 2008-11-19 | Wright David P (President and CEO) | Buy | 45,300 | .96 | 43,488 |
| 2008-05-29 | Wright David P (President and CEO) | Buy | 2,500 | 2.90 | 7,250 |
| 2008-05-28 | Wright David P (President and CEO) | Buy | 7,500 | 2.91 | 21,825 |
| 2007-08-07 | Mpm Asset Management Investors 2004 Bviii Llc (10% Owner) | Buy | 125,000 | 7.70 | 962,500 |
| 2007-08-07 | Simon Nicholas J Iii (10% Owner) | Buy | 125,000 | 7.70 | 962,500 |
| 2007-08-07 | Schaffer Derace L (Other) | Buy | 40,000 | 7.70 | 308,000 |
| 2007-08-07 | Pappajohn John (Chairman and Secretary) | Buy | 100,000 | 7.70 | 770,000 |
| 2007-08-03 | Kinley Matthew P (Other) | Buy | 50,000 | 7.66 | 383,000 |
| 2007-08-03 | Aguiar Eric (10% Owner) | Buy | 125,000 | 7.66 | 957,500 |
| 2007-08-03 | Schaffer Derace L (Director) | Buy | 100,000 | 7.55 | 755,000 |
| 2007-08-03 | Pappajohn John (Chairman and Secretary) | Buy | 100,000 | 7.66 | 766,000 |
| 2007-05-16 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.54 | 37,700 |
| 2007-05-16 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-16 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-15 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.54 | 37,700 |
| 2007-05-15 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-15 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-14 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.54 | 37,700 |
| 2007-05-14 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-14 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-11 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.55 | 37,750 |
| 2007-05-11 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-11 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-10 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.55 | 37,750 |
| 2007-05-10 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-10 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-09 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.54 | 37,700 |
| 2007-05-09 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-09 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.54 | 75,400 |
| 2007-05-08 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.55 | 37,750 |
| 2007-05-08 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-08 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-07 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.55 | 37,750 |
| 2007-05-07 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-07 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-04 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.55 | 37,750 |
| 2007-05-04 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-04 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-03 | Kinley Matthew P (President & Treasurer) | Buy | 5,000 | 7.55 | 37,750 |
| 2007-05-03 | Schaffer Derace L (Vice Chairman and CEO) | Buy | 10,000 | 7.55 | 75,500 |
| 2007-05-03 | Pappajohn John (Chairman and Secretary) | Buy | 10,000 | 7.55 | 75,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Altimmune, Inc. (symbol ALT, CIK number 1326190) see the Securities and Exchange Commission (SEC) website.